InterventionsReview

Risk of neoplasms with semaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Figure 1. PRISMA flowchart of 19 included RCTs.
Open the figure at full size
Figure 1. PRISMA flowchart of 19 included RCTs.PRISMA flowchart of 19 included RCTs.Zhong et al.

Frontiers in Pharmacology

The paper

Zhong Y, Tan X, Zhang L et al.

Frontiers in Pharmacology · 3 Sep 2026

doi.org/10.3389/fphar.2026.1916932PubMed 42757217

More on Type 2 diabetes